• Enhanced Features Added to Clinical Supplies Labelling Platform

Laboratory Products

Enhanced Features Added to Clinical Supplies Labelling Platform

Jul 01 2020

Based upon its collaborative work with three leading pharmaceutical companies, PRISYM ID has launched an update to its flagship software solution for clinical supplies labelling. Enhancements to PRISYM 360 include the automation of booklet production with improved regulatory rules and language management and a new compliance-friendly product - the 3-Step Clinical Label Print Process.

The update is part of PRISYM ID’s continued responsiveness to the needs of organisations undertaking clinical trials. Clients are seeking to leverage the latest technology improvements to be able to quickly launch studies in multiple countries at the same time, while building in flexibility to allow for subsequent drug dosage or administration changes. They need processes which are fully auditable, are logged and that offer traceability for every printed label or booklet.

The 3-Step Clinical Label Print Process encapsulates industry best practice, significantly reducing the possibility of individual user error when printing single page labels. It will not let the same person raise and approve labels, it ensures a test label is printed and stored electronically, prints test labels with a watermark, and creates summary reports and audit trails. 

New content management controls are designed to merge the right rules and phrase content together for particular drugs and protocols, and ensure they are produced in the right languages for the countries in which trials are run. They can replace email and disparate, clunky systems that have manual steps and are liable to user error. 

Simon Jones, Vice President of Product Marketing, said: “We have worked closely with three key customers who explained to us their challenges in quickly creating multi-page booklets for studies in 40+ countries, especially where participating countries have specific regulatory requirements in respect of language, indications, warnings, precautions, and symbols.

“This update is therefore all about clinical trial functionality enhancements which streamline the process of creating a label or a booklet and getting clinical trials started more quickly. Our 3-Step Clinical Label Print Process eliminates errors, risks and ensures full accountability.”

More information online


Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions

Events

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

EMC2024

Aug 25 2024 Copenhagen, Denmark

Lab Cambodia 2024

Aug 28 2024 Phnom Penh, Cambodia

JASIS 2024

Sep 04 2024 Chiba, Tokyo, Japan

BMSS-BSPR Super Meeting 2024

Sep 04 2024 University of Warwick, Coventry, UK

View all events